Facilitators and barriers of human papillomavirus vaccine uptake in young females 18–26 years old in Singapore: A qualitative study

Vaccine - Tập 37 - Trang 6030-6038 - 2019
Andrea Su En Lim1, Raymond Boon Tar Lim2
1Preventive Medicine Resident, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore
2Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, Singapore 117549, Singapore

Tài liệu tham khảo

World Health Organisation. Human papillomavirus (HPV) and cervical cancer: Fact Sheet. Available from: URL: www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer [accessed 2018 Aug 20] de Martel, 2017, Worldwide burden of cancer attributable to HPV by site, country and HPV type, Int J Cancer, 141, 664, 10.1002/ijc.30716 World Health Organisation, 2017, Human Papillomavirus vaccines: WHO position paper, ’May 2017, Vaccine, 35, 5753, 10.1016/j.vaccine.2017.05.069 The US National Vaccine Advisory Committee, 2016, Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee, Public Health Rep, 131, 17, 10.1177/003335491613100106 Schiller, 2012, A review of clinical trials of human papillomavirus prophylactic vaccines, Vaccine, 30, F123, 10.1016/j.vaccine.2012.04.108 Markowitz, 2013, Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition and Examination Surveys, 2003–2010, J Infect Dis, 208, 385, 10.1093/infdis/jit192 Benard VB et al. Population-based incidence rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. JAMA Oncol. Published online September 29; 2016 Mesher, 2014, Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England, Vaccine, 32, 26, 10.1016/j.vaccine.2013.10.085 Garland, 2016, Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience, Clin Infect Dis, 63, 10.1093/cid/ciw354 Lu, 2011, Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis, BMC Infect Dis, 11, 13, 10.1186/1471-2334-11-13 De Vincenzo, 2014, Long-term efficacy and safety of human papillomavirus vaccination, Int J Women’s Health, 6, 999, 10.2147/IJWH.S50365 Ferris, 2014, Long-term study of a quadrivalent human papillomavirus vaccine, Paediatrics, 134, e657, 10.1542/peds.2013-4144 Klein, 2012, Safety of quadrivalent human papillomavirus vaccine administered routinely to females, Arch Paediatr Adolesc Med, 166, 1140, 10.1001/archpediatrics.2012.1451 Macartney, 2013, Safety of human papillomavirus vaccines: a review, Drug Saf, 36, 393, 10.1007/s40264-013-0039-5 Vichnin, 2015, An overview of quadrivalent human papillomavirus vaccine safety 2006–2015, Paediatr Infect Dis J, 34, 983, 10.1097/INF.0000000000000793 Kavanagh, 2014, Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types, Br J Cancer, 110, 2804, 10.1038/bjc.2014.198 National HPV Vaccination Program Register Australia. HPV Vaccination Coverage 2017. Available from: URL: http://www.hpvregister.org.au/research/coverage-data/HPV-Vaccination-Coverage-2017 [accessed 2019 July 25] Public Health England. Human Papillomavirus (HPV) vaccination coverage in adolescent females in England: 2016/17. Available from: URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/666087/HPV_vaccination_coverage_in_adolescent_females_in_England_2016_to_2017.pdf [accessed 2018 Feb 28] Bruni, 2016, Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis, Lancet Global Health, 4, e453, 10.1016/S2214-109X(16)30099-7 Santhanes, 2018, Factors influencing intention to obtain the HPV vaccine in South East Asia and Western Pacific Regions: a systematic review and meta-analysis, Sci Rep, 8, 3640, 10.1038/s41598-018-21912-x Ueda, 2015, Japan’s failure to vaccinate girls against human papillomavirus, Am J Obstet Gynaecol, 212, 405, 10.1016/j.ajog.2014.11.037 Buang, 2018, Human papillomavirus immunization of adolescent girls: improving coverage through multisectoral collaboration in Malaysia, Br Med J, 363 Zhuang, 2016, Knowledge, attitudes and practices regarding human papillomavirus vaccination among young women attending a tertiary institution in Singapore, Singapore Med J, 57, 329, 10.11622/smedj.2016108 Ministry of Health Singapore. Parliamentary Q&A on HPV 11 May 2015. Available from: URL: https://moh.gov.sg/content/moh_web/home/pressRoom/parliamentary_QA/2015.hpv.html [accessed 22 Sept 2017] Lee, 2011, Cost-effectiveness of different human papillomavirus vaccines in Singapore, BMC Public Health, 11, 203, 10.1186/1471-2458-11-203 Ministry of Health Singapore, Health Promotion Board Singapore. HealthHub: FAQs on HPV and HPV vaccination. Last reviewed 13 Jan 2015. Available from: URL: https://www.healthhub.sg/live-healthy/312/HPV_immunisation_FAQ [accessed 16 March 2018] Loke, 2017, The uptake of human papillomavirus vaccination and its associated factors among adolescents: a systematic review, J Prim Care Community Health, 8, 349, 10.1177/2150131917742299 Chan, 2012, A systematic review of literature about women’s knowledge and attitudes towards Human Papillomavirus (HPV) vaccination, Public Health Nurs, 29, 481, 10.1111/j.1525-1446.2012.01022.x Holman, 2014, Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature, JAMA Pediatrics, 168, 76, 10.1001/jamapediatrics.2013.2752 Rambout, 2014, Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review, Prev Med, 58, 22, 10.1016/j.ypmed.2013.10.009 Ferrer, 2014, Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis, BMC Public Health, 14, 700, 10.1186/1471-2458-14-700 Siu, 2013, Barriers to receiving human papillomavirus vaccination among female students in a university in Hong Kong, Culture Health Sexuality, 15, 1071, 10.1080/13691058.2013.807518 Mortensen, 2010, Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study, BMC Public Health, 10, 68, 10.1186/1471-2458-10-68 Teitelman, 2011, Social cognitive and clinical factors associated with HPV vaccine initiation among urban, economically disadvantaged women, J Obstetric Gynaecol Neonatal Nurs, 40, 691, 10.1111/j.1552-6909.2011.01297.x Hopfer, 2011, College women’s HPV vaccine decision narratives, Qual Health Res, 21, 262, 10.1177/1049732310383868 Tan, 2017, Barriers to human papillomavirus (HPV) vaccine uptake in Asia: a pilot study, J Dermatol Sci, 86, e1, 10.1016/j.jdermsci.2017.02.145 Singapore Cancer Registry Annual Registry Report 2015. National Registry of Diseases Office. https://www.nrdo.gov.sg/docs/librariesprovider3/Publications-Cancer/cancer-registry-annual-report-2015_web.pdf?sfvrsn=1dd97be4_10 Overview of Hong Kong Cancer Statistics of 2015. Hong Kong Cancer Registry, Hospital Authority. https://www3.ha.org.hk/cancereg/pdf/overview/Summary%20of%20CanStat%202015.pdf Human Papillomavirus and Vaccine. Department of Health. The Government of the Hong Kong Special Administrative Region. https://www.cervicalscreening.gov.hk/english/hum/hum_ccv.html Tay, 2015, Vaccine misconceptions and low HPV vaccination take-up rates in Singapore, Asian Pac J Cancer Prev, 16, 5119, 10.7314/APJCP.2015.16.12.5119 McLeroy, 1988, An ecological perspective on health promotion programs, Health Educat Behav, 15, 351 Waller, 2013, Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory, Prev Med, 56, 35, 10.1016/j.ypmed.2012.10.028 NHS Scotland. HPV Vaccine. Last reviewed 28 June 2018. Available from: URL: https://www.nhsinform.scot/healthy-living/immunisation/vaccines/hpv-vaccine [accessed 2018 July 25] Cancer Council Australia. HPV Vaccine. Available from: URL: http://www.hpvvaccine.org.au [accessed 2018 July 25] Van Den Brink T. The effects of modernization: smart, working women and filial piety in ageing Singapore. Last reviewed 2017 Jan 30. Available from: URL: https://essay.utwente.nl/71853/1/VandenBrink_BA_BMS.pdf [accessed 2019 July 30] Leaving the nest is proving difficult for young adults in Asia. Today Online [newspaper on the internet]. 2016 Nov 30 [date cited 2019 Jul 30]. Available from: URL: https://www.todayonline.com/world/asia/leaving-nest-proving-difficult-young-adults-asia Beavis, 2017, Reasons for persistent suboptimal rates of HPV vaccination in the US: shifting the focus from sexuality to education and awareness, Gynaecol Oncol, 145, 4, 10.1016/j.ygyno.2017.03.032 Tay, 2018, Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore, Singapore Med J, 59, 370, 10.11622/smedj.2017085 Health Promotion Board Singapore. Fact Sheet on National School-Based HPV Vaccination Programme 2019. Last reviewed March 2019. Available from: URL: https://www.healthhub.sg/sites/Assets/Programs/Fact%20Sheet%20on%20HPV%20for%20parents_MOH.pdf [accessed 2019 July 12] Baker JA. Secondary 1 female students to get free opt-in HPV vaccination against cervical cancer. Channel News Asia [newspaper on the internet]. 2019 Mar 6 [dated cited 2019 Jul 12]. Available from: URL: https://www.channelnewsasia.com/news/singapore/sec-1-female-students-free-hpv-vaccine-against-cervical-cancer-11316882 Ministry of Health Singapore. MOH Committee of Supply (COS) Factsheet 2019. Last reviewed March 2019. Available from: URL: https://www.moh.gov.sg/docs/librariesprovider5/default-document-library/cos-factsheet-empowering-singaporeans-to-live-healthily2d516061f5554318a7bd71d9c1e38414.pdf [accessed 2019 July 25] Harder, 2018, Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review, BMC Med, 16, 110, 10.1186/s12916-018-1098-3 Patel, 2018, The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?, Euro Surveill, 23, 1700737, 10.2807/1560-7917.ES.2018.23.41.1700737 Kmietowicz, 2018, Boys in England to get HPV vaccine from next year, BMJ, 24